Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis

NCT05404074 is registered in ClinicalTrials.gov with InDex Pharmaceuticals as lead sponsor.

NCT NCT05404074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05404074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis
Lead sponsor
InDex Pharmaceuticals
Phase
Phase 1
Overall status
Unknown status
Start date
November 22, 2021
Completion date
October 30, 2022
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis